Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Promoting blood circulation" refers collectively to mechanisms that enhance or restore blood flow through tissues and organs. This process involves complex regulation by numerous blood vessel cell types (especially smooth muscle and endothelial cells), multiple classes of molecular targets (such as angiotensin receptors, ion channels, enzymes like nitric oxide synthase, and neurotransmitter receptors), and is fundamental in the prevention and treatment of cardiovascular disorders. However, it is not a specific molecule, protein, or receptor, so cannot be classified as a druggable target in a structured database. Interventions that "promote blood circulation" can work by a variety of mechanisms, including vasodilation, reduction of blood viscosity, or modulation of neural and hormonal signaling pathways[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Promoting blood circulation.